March 2010 Volume 45 Number 3, pp 419 - 612
---------------------------------------------------------------------
Gouty Arthritis
Special issue and web focus
Immunology & Cell Biology is proud to present a special issue and web
focus on Gouty Arthritis. In the January 2010 issue, Immunology & Cell
Biology reviews recent advances in Gouty Arthritis, placed in the wider
context of immunology while the accompanying web focus presents the
historical context of the problem of gouty inflammation.
Select articles have been made free for a limited time.
Take advantage of the special issue and web focus on Gouty Arthritis today!
http://links.ealert.nature.com/ctt?kn=105&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
----------------------
EDITORIAL
----------------------
Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis:
the risk-benefit balancing act
A Tefferi
http://links.ealert.nature.com/ctt?kn=104&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Decisions to register for the National Marrow Donor Program: rational
vs emotional appeals
J L Studts, J L Ruberg, S A McGuffin and L M Roetzer
Abstract: http://links.ealert.nature.com/ctt?kn=100&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=99&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa
for adult patients undergoing haploidentical SCT
S O Ciurea, R Saliba, G Rondon, S Pesoa, P Cano, M Fernandez-Vina,
S Qureshi, L L Worth, J McMannis, P Kebriaei, R B Jones, M Korbling,
M Qazilbash, E J Shpall, S Giralt, M de Lima, R E Champlin and J Gajewski
Abstract: http://links.ealert.nature.com/ctt?kn=102&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=101&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Bone markers after total body irradiation in childhood
A-C Couto-Silva, C Trivin, H Esperou, J Michon, A Baruchel, J-C Souberbielle
and R Brauner
Abstract: http://links.ealert.nature.com/ctt?kn=94&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=96&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Cellular immune parameters associated with spontaneous control of CMV
in children who underwent transplantation
V Guerin, J-H Dalle, B Pedron, M Ouachee-Chardin, K Yakouben, A Baruchel
and G Sterkers
Abstract: http://links.ealert.nature.com/ctt?kn=97&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=98&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome:
prognostic significance of pre-transplant IPSS score and comorbidity
J-H Lee, J-H Lee, S-N Lim, D-Y Kim, S H Kim, Y-S Lee, Y-A Kang, S-I Kang,
M J Jeon, M Seol, E-J Seo, H S Chi, C J Park, S Jang, S-C Yun and K-H Lee
Abstract: http://links.ealert.nature.com/ctt?kn=110&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=109&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a
predictive transplant score based on transfusion requirement, spleen size
and donor type
A Bacigalupo, M Soraru, A Dominietto, S Pozzi, S Geroldi, M T Van Lint,
A Ibatici, A M Raiola, F Frassoni, F De Stefano, S Verdiani, L Casarino and
G Barosi
Abstract: http://links.ealert.nature.com/ctt?kn=108&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=124&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY
in patients with metastatic breast cancer
A J H M Fleskens, R I Lalisang, G M J Bos, M van Gelder, R L H Jansen and
H C Schouten
Abstract: http://links.ealert.nature.com/ctt?kn=122&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=120&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased
hospital utilization and low TRM
S R Solomon, R H Matthews, A M Barreras, A Bashey, K L Manion, K McNatt,
D Speckhart, D G Connaghan, L E Morris and H K Holland
Abstract: http://links.ealert.nature.com/ctt?kn=119&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=116&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
High-dose chemotherapy and autologous stem cell transplant in adolescent
patients with relapsed or refractory Hodgkin's lymphoma
S Akhtar, A El Weshi, M Rahal, M Abdelsalam, H Al Husseini and I Maghfoor
Abstract: http://links.ealert.nature.com/ctt?kn=114&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=111&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Total body MRI-governed involved compartment irradiation combined with
high-dose chemotherapy and stem cell rescue improves long-term survival
in Ewing tumor patients with multiple primary bone metastases
S Burdach, U Thiel, M Schoniger, R Haase, A Wawer, M Nathrath, H Kabisch,
C Urban, H J Laws, U Dirksen, M Steinborn, J Dunst and H Jurgens,
on behalf of the Meta-EICESS Study Group
Abstract: http://links.ealert.nature.com/ctt?kn=37&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=38&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Phase I trial of autologous hematopoietic SCT with escalating doses of
topotecan combined with CY and carboplatin in patients with relapsed
or persistent ovarian or primary peritoneal carcinoma
M R Litzow, P P Peethambaram, S L Safgren, G L Keeney, S M Ansell,
A Dispenzieri, M A Elliott, D A Gastineau, M A Gertz, D J Inwards,
M Q Lacy, I N M Micallef, L F Porrata, W L Lingle, L C Hartmann,
M H Frost, B A Barrette, H J Long, V J Suman, J M Reid, M M Ames and
S H Kaufmann
Abstract: http://links.ealert.nature.com/ctt?kn=39&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=40&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
CR represents an early index of potential long survival in multiple myeloma
M Wang, K Delasalle, L Feng, S Thomas, S Giralt, M Qazilbash, B Handy,
J J Lee and R Alexanian
Abstract: http://links.ealert.nature.com/ctt?kn=25&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=27&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Comparative assessment of telomere length before and after hematopoietic
SCT: role of grafted cells in determining post-transplant telomere status
M Ruella, A Rocci, I Ricca, C Carniti, C Labetti Bodoni, M Ladetto,
D Caracciolo, M Boccadoro, C Carlo-Stella, P Corradini and C Tarella
Abstract: http://links.ealert.nature.com/ctt?kn=28&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=29&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Differential prognostic impact of pretransplant comorbidity on transplant
outcomes by disease status and time from transplant: a single Japanese transplant
centre study
K Kataoka, Y Nannya, K Ueda, K Kumano, T Takahashi and M Kurokawa
Abstract: http://links.ealert.nature.com/ctt?kn=30&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=31&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Comparison of infectious complications during induction/consolidation
chemotherapy versus allogeneic hematopoietic stem cell transplantation
C Orasch, M Weisser, D Mertz, A Conen, D Heim, S Christen, A Gratwohl,
M Battegay, A Widmer and U Fluckiger
Abstract: http://links.ealert.nature.com/ctt?kn=8&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=13&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Assessment of CD4 T-lymphocyte reactivity by the Cylex ImmuKnow assay
in patients following allogeneic hematopoietic SCT
B Gesundheit, E Budowski, M Israeli, M Y Shapira, I B Resnick, R Bringer,
Y Azar, S Samuel, L Dray, A Amar, D Kristt and R Or
Abstract: http://links.ealert.nature.com/ctt?kn=14&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=11&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Cytomegalovirus infection and disease after reduced intensity conditioning
allogeneic stem cell transplantation: single-centre experience
J L Pinana, R Martino, P Barba, N Margall, M C Roig, D Valcarcel, J Sierra and
N Rabella
Abstract: http://links.ealert.nature.com/ctt?kn=12&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=3&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Lack of prompt expansion of cytomegalovirus pp65 and IE-1-specific IFN[gamma]
CD8+ and CD4+ T cells is associated with rising levels of pp65 antigenemia
and DNAemia during pre-emptive therapy in allogeneic hematopoietic stem
cell transplant recipients
N Tormo, C Solano, I Benet, M A Clari, J Nieto, R de la Camara, J Lopez,
N Lopez-Aldeguer, J C Hernandez-Boluda, M J Remigia, A Garcia-Noblejas,
C Gimeno and D Navarro
Abstract: http://links.ealert.nature.com/ctt?kn=4&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=1&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Vector prime protein boost vaccination in the setting of myeloablative-induced
lymphopenia suppresses growth of leukemia and solid tumors
T H Han, Y Tang, Y H Park, J Maynard, P Li, H Akbulut, L Petersen and A Deisseroth
Abstract: http://links.ealert.nature.com/ctt?kn=2&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=5&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Outcome of patients developing GVHD after DLI given to treat CML
relapse: a study by the chronic leukemia working party of the EBMT
Y Chalandon, J R Passweg, C Schmid, E Olavarria, F Dazzi, M P Simula,
P Ljungman, A Schattenberg, T de Witte, S Lenhoff, P Jacobs, L Volin,
S Iacobelli, J Finke, D Niederwieser and C Guglielmi, on behalf of the
Chronic Leukemia Working Party of the European Group for Blood and Marrow
Transplantation (EBMT)
Abstract: http://links.ealert.nature.com/ctt?kn=74&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=76&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Topical tranilast for treatment of the early stage of mild dry eye associated
with chronic GVHD
Y Ogawa, M Dogru, M Uchino, Y Tatematsu, M Kamoi, Y Yamamoto, J Ogawa, R Ishida,
M Kaido, S Hara, Y Matsumoto, T Kawakita, S Okamoto and K Tsubota
Abstract: http://links.ealert.nature.com/ctt?kn=69&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=70&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Barriers to mental health service use among hematopoietic SCT survivors
C E Mosher, K N DuHamel, C M Rini, Y Li, L Isola, L Labay, S Rowley,
E Papadopoulos, C Moskowitz, E Scigliano, C Grosskreutz and W H Redd
Abstract: http://links.ealert.nature.com/ctt?kn=71&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=72&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
----------------------
LETTERS TO THE EDITOR
----------------------
Severe pulmonary toxoplasmosis after allo-SCT in two patients: from Toxoplasma
genotyping to clinical management
L Delhaes, J-C Mraz, E Frealle, I Durand-Joly, L Magro, D Ajzenberg,
M-L Darde, E Dei-Cas and I Yakoub-Agha
http://links.ealert.nature.com/ctt?kn=66&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Allo-SCT for hematological malignancies in the setting of HIV
M N Polizzotto, M Skinner, M F Cole-Sinclair, S S Opat, A Spencer and
S Avery
http://links.ealert.nature.com/ctt?kn=68&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Comparison of immune recovery in recipients of unmanipulated vs T-cell-depleted
grafts from unrelated donors in a multicenter randomized phase II-III trial
(T-cell depletion trial)
C A Keever-Taylor, J E Wagner, N A Kernan, T N Small, S L Carter, J S Thompson,
G A Cloud and L S Lamb
http://links.ealert.nature.com/ctt?kn=59&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Pancreatic atrophy is associated with gastrointestinal chronic GVHD following
allogeneic PBSC transplantation
H Nakasone, A Ito, H Endo, M Kida, I Koji and K Usuki
http://links.ealert.nature.com/ctt?kn=57&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Central nervous system immune reconstitution inflammatory syndrome (IRIS)
after hematopoietic SCT
L Airas, M Paivarinta, M Roytta, J Karhu, M Kauppila, M Itala-Remes and K Remes
http://links.ealert.nature.com/ctt?kn=55&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Potential role of adoptively transferred allogeneic WT1-specific CD4+ and
CD8+ T lymphocytes for the sustained remission of refractory AML
Y-J Kim, S-G Cho, S Lee, M-S Kim, E-K Kim, B-S Cho, H-J Sohn, H B Choi,
K-S Eom, C-K Min, H-J Kim, Y-G Kim, D-W Kim, J-W Lee, W-S Min, C-C Kim and T-G Kim
http://links.ealert.nature.com/ctt?kn=53&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Munchausen's syndrome in the allogeneic stem cell transplantation
setting: a rare but potentially devastating condition
M-A Archambault-Grenier, J Roy, N Beauchemin, S Cohen, S Lachance and
T Kiss
http://links.ealert.nature.com/ctt?kn=52&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Unexpectedly high AUC levels in a child who received intravenous busulfan
before stem cell transplantation
T Nishikawa, Y Okamoto, T Tanabe, Y Shinkoda, Y Kodama, M Higashi,
H Hirano, K Arita and Y Kawano
http://links.ealert.nature.com/ctt?kn=89&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
MSC for the improvement of hematopoietic engraftment
I Resnick, P Stepensky, G Elkin, C Barkatz, O Gurevich, T Prigozhina,
E Pikarsky, E Waldman, A Amar, S Samuel, M Shapira, M Weintraub and R Or
http://links.ealert.nature.com/ctt?kn=87&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Hematopoietic stem cell transplantation for X-linked thrombocytopenia from
a mild symptomatic carrier
M Okuya, H Kurosawa, T Kubota, K Endoh, A Ogiwara, S Nonoyama, S Hagisawa,
Y Sato, T Matsushita, K Fukushima, K Sugita, T Sato and O Arisaka
http://links.ealert.nature.com/ctt?kn=85&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
Positron emission tomography in the diagnosis and therapeutic monitoring
of post-transplant lymphoproliferative disorder after cord blood transplantation
K Kataoka, S Seo, S Ota, T Takahashi and M Kurokawa
http://links.ealert.nature.com/ctt?kn=83&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
---------------------------------------------------------------------
Submit your research through our online submission site at
http://links.ealert.nature.com/ctt?kn=123&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0.
Papers benefit from wide readership through hosting on nature.com and
inclusion in the leading abstracting and indexing services. Rapid
publication is also assured through Advance Online Publication.
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=62&m=34689924&r=MTc1NjE0NTQ4OQS2&b=2&j=Njg3MjU5MDMS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2010 Nature Publishing Group
=====================================================================
